190 related articles for article (PubMed ID: 23281170)
41. Reconstructing very short TE phase rotation spectral data collected with multichannel phased-array coils at 3 T.
Wijtenburg SA; Knight-Scott J
Magn Reson Imaging; 2011 Sep; 29(7):937-42. PubMed ID: 21550744
[TBL] [Abstract][Full Text] [Related]
42. Selective proton-observed, carbon-edited (selPOCE) MRS method for measurement of glutamate and glutamine
De Feyter HM; Herzog RI; Steensma BR; Klomp DWJ; Brown PB; Mason GF; Rothman DL; de Graaf RA
Magn Reson Med; 2018 Jul; 80(1):11-20. PubMed ID: 29134686
[TBL] [Abstract][Full Text] [Related]
43. An investigation of glutamate quantification with PRESS and MEGA-PRESS.
Cheng H; Wang A; Newman S; Dydak U
NMR Biomed; 2021 Feb; 34(2):e4453. PubMed ID: 33617070
[TBL] [Abstract][Full Text] [Related]
44. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
45. Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: a phantom study at 4 Tesla.
Henry ME; Lauriat TL; Shanahan M; Renshaw PF; Jensen JE
J Magn Reson; 2011 Feb; 208(2):210-8. PubMed ID: 21130670
[TBL] [Abstract][Full Text] [Related]
46. Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: a pilot study with application to magnetisation transfer measurements.
Yiannakas MC; Kearney H; Samson RS; Chard DT; Ciccarelli O; Miller DH; Wheeler-Kingshott CA
Neuroimage; 2012 Nov; 63(3):1054-9. PubMed ID: 22850571
[TBL] [Abstract][Full Text] [Related]
47. Hypothalamic glutamate levels following serotonergic stimulation: a pilot study using 7-Tesla magnetic resonance spectroscopy in healthy volunteers.
Jacobs GE; der Grond Jv; Teeuwisse WM; Langeveld TJ; van Pelt J; Verhagen JC; de Kam ML; Cohen AF; Zitman FG; van Gerven JM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):486-91. PubMed ID: 20138102
[TBL] [Abstract][Full Text] [Related]
48. TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T.
Srinivasan R; Cunningham C; Chen A; Vigneron D; Hurd R; Nelson S; Pelletier D
Neuroimage; 2006 May; 30(4):1171-8. PubMed ID: 16431138
[TBL] [Abstract][Full Text] [Related]
49. Short echo time in vivo prostate ¹H-MRSI.
Venugopal N; McCurdy B; Al Mehairi S; Alamri A; Sandhu GS; Sivalingam S; Drachenberg D; Ryner L
Magn Reson Imaging; 2012 Feb; 30(2):195-204. PubMed ID: 22154684
[TBL] [Abstract][Full Text] [Related]
50. In vivo detection of 2-hydroxyglutarate in brain tumors by optimized point-resolved spectroscopy (PRESS) at 7T.
Ganji SK; An Z; Tiwari V; McNeil S; Pinho MC; Pan E; Mickey BE; Maher EA; Choi C
Magn Reson Med; 2017 Mar; 77(3):936-944. PubMed ID: 26991680
[TBL] [Abstract][Full Text] [Related]
51. Optimized multi-voxel TE-averaged PRESS for glutamate detection in the human brain at 3T.
Hatay GH; Ozturk-Isik E
J Magn Reson; 2023 Nov; 356():107574. PubMed ID: 37922677
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous observation of glutamate, gamma-aminobutyric acid, and glutamine in human brain at 4.7 T using localized two-dimensional constant-time correlation spectroscopy.
Watanabe H; Takaya N; Mitsumori F
NMR Biomed; 2008 Jun; 21(5):518-26. PubMed ID: 18351694
[TBL] [Abstract][Full Text] [Related]
53. [Measurement of glutamine concentration in Zelanian rabbits' skeletal muscle by non-invasive magnetic resonance spectroscopy].
Fan YP; Yu JC; Zhang F; He GZ; Feng F; Li XZ; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):622-5. PubMed ID: 18051717
[TBL] [Abstract][Full Text] [Related]
54. Reliable gamma aminobutyric acid measurement using optimized PRESS at 3 T.
Napolitano A; Kockenberger W; Auer DP
Magn Reson Med; 2013 Jun; 69(6):1528-33. PubMed ID: 22807127
[TBL] [Abstract][Full Text] [Related]
55. 1H magnetic resonance spectroscopy at 3 T in cryptogenic and mesial temporal lobe epilepsy.
Riederer F; Bittsanský M; Schmidt C; Mlynárik V; Baumgartner C; Moser E; Serles W
NMR Biomed; 2006 Aug; 19(5):544-53. PubMed ID: 16521092
[TBL] [Abstract][Full Text] [Related]
56. Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T.
Prescot AP; Richards T; Dager SR; Choi C; Renshaw PF
NMR Biomed; 2012 Nov; 25(11):1245-52. PubMed ID: 22407923
[TBL] [Abstract][Full Text] [Related]
57. Detection of brain glutamate and glutamine in spectroscopic images at 4.1 T.
Mason GF; Pan JW; Ponder SL; Twieg DB; Pohost GM; Hetherington HP
Magn Reson Med; 1994 Jul; 32(1):142-5. PubMed ID: 7916115
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis.
Carew JD; Nair G; Pineda-Alonso N; Usher S; Hu X; Benatar M
Amyotroph Lateral Scler; 2011 May; 12(3):185-91. PubMed ID: 21143004
[TBL] [Abstract][Full Text] [Related]
59. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis.
Han J; Ma L
J Magn Reson Imaging; 2010 Feb; 31(2):305-8. PubMed ID: 20099342
[TBL] [Abstract][Full Text] [Related]
60. The relation between peripheral and central glutamate and glutamine in healthy male volunteers.
Shulman Y; Grant S; Seres P; Hanstock C; Baker G; Tibbo P
J Psychiatry Neurosci; 2006 Nov; 31(6):406-10. PubMed ID: 17136218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
